Transient congenital hypothyroidism

Transient congenital hypothyroidism (TCH) is a condition in which a newborn has insufficient thyroid hormone levels at birth that spontaneously normalize over time, typically within the first few months to years of life. Unlike permanent congenital hypothyroidism, the thyroid gland eventually recovers normal function. The condition affects the thyroid gland and, if untreated during the critical period of early brain development, can impact the neurological system, potentially leading to developmental delays and cognitive impairment. The causes of transient congenital hypothyroidism are diverse and include maternal factors such as exposure to maternal thyrotropin receptor-blocking antibodies, maternal use of antithyroid medications, iodine deficiency or excess (particularly in premature infants), and certain genetic factors affecting thyroid hormone synthesis. Prematurity and low birth weight are also recognized risk factors. Key symptoms in the neonatal period may include prolonged jaundice, feeding difficulties, decreased activity, constipation, hypothermia, a large fontanelle, and a hoarse cry, though many affected newborns are identified through routine newborn screening before clinical symptoms become apparent. Treatment involves thyroid hormone replacement therapy with levothyroxine, initiated promptly after detection through newborn screening to prevent neurodevelopmental complications. The treatment is continued until approximately age 2–3 years, at which point a trial off medication is conducted to determine whether thyroid function has normalized. Regular monitoring of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) levels is essential during treatment and after discontinuation to confirm the transient nature of the condition. With early detection and appropriate management, the prognosis for children with transient congenital hypothyroidism is generally excellent.

Common questions about Transient congenital hypothyroidism